Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$24.89 3.67%
Market Cap
$580.6M
Price Target
Refer to Report
Volume
127.4K
52wk Range
$7.65 - $45
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).